Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aytu Biopharma Inc
(NQ:
AYTU
)
2.690
-0.060 (-2.18%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Aytu Biopharma Inc
< Previous
1
2
3
4
Next >
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
August 08, 2024
Via
ACCESSWIRE
Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
August 06, 2024
Via
ACCESSWIRE
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
June 18, 2024
Via
ACCESSWIRE
Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024
May 29, 2024
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and...
Via
Newsfile
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
April 03, 2024
Via
ACCESSWIRE
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
November 30, 2023
Via
ACCESSWIRE
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
November 14, 2023
Via
ACCESSWIRE
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
May 23, 2024
Via
ACCESSWIRE
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
May 08, 2024
Via
ACCESSWIRE
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
February 14, 2024
Via
ACCESSWIRE
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
February 07, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
January 23, 2024
Via
ACCESSWIRE
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
November 08, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
October 26, 2023
Via
ACCESSWIRE
Aytu BioPharma Inc. (NASDAQ: AYTU) Near the Top of Equities by Percentage Gain on 9/28
September 28, 2023
Via
Investor Brand Network
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
November 07, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
October 09, 2023
Via
ACCESSWIRE
Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
September 26, 2023
Via
ACCESSWIRE
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
September 21, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
September 13, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market
June 13, 2023
Via
ACCESSWIRE
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Via
Newsfile
Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
July 31, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
July 10, 2023
Via
ACCESSWIRE
Aytu to Participate in the Maxim Group Virtual Healthcare Conference
June 14, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
June 09, 2023
Via
ACCESSWIRE
Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results
May 11, 2023
Via
ACCESSWIRE
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
May 04, 2023
Via
ACCESSWIRE
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility
May 01, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.